Related by context. Frequent words. (Click for all words.) 74 Eye Disease 67 AREDS 60 related Macular Degeneration 59 retrospective cohort study 59 Diabetic Macular Edema 58 prospective observational 57 NHANES III 57 subanalysis 56 Investigative Dermatology 56 Rosuvastatin 56 lipid lowering therapy 56 substudy 55 antihypertensive therapy 55 multicenter study 55 double blinded placebo 55 Chlamydia pneumoniae 55 Thrombolysis 54 Observational studies 54 acne vulgaris 54 placebo controlled clinical 54 Metabolomics 54 Antihypertensive 54 carotid artery stenting 54 diabetic macular edema DME 54 tolvaptan 54 Dasatinib 54 placebo controlled clinical trials 54 phase IIb clinical 54 lipid profiles 54 secondary hyperparathyroidism 54 liver transplant recipients 54 placebo controlled studies 54 tibolone 54 subgroup analyzes 54 non alcoholic steatohepatitis 53 Mipomersen 53 prospective cohort 53 elevated CRP 53 primary hypercholesterolemia 53 Combination therapy 53 Clinical Endocrinology & 53 nonrandomized 53 #:#-# [029] 53 placebo controlled trials 53 disease NAFLD 53 Natural S equol 53 antihypertensive medications 53 irbesartan 53 randomized controlled clinical trials 53 retinal vein occlusion 53 Wet AMD 53 hydroxychloroquine 53 pancreatic insufficiency 53 phase IIa 53 prospectively defined 53 PRADAXA 53 calcium supplementation 53 pharmacodynamic effects 53 cardiometabolic risk 53 elevated triglycerides 53 ximelagatran 53 cognitively normal 53 ischemic cardiomyopathy 53 EVIZON 53 COPAXONE R 53 randomized clinical 53 placebo controlled randomized 52 candesartan 52 longitudinal studies 52 randomized clinical trials 52 PRECiSE 52 PREZISTA r 52 teriparatide 52 attention-deficit/hyperactivity disorder ADHD 52 Arch Intern Med 52 Diabetic Retinopathy 52 nonmelanoma skin cancer 52 Phase 1b trial 52 Estradiol 52 Multicenter 52 RCTs 52 zinc supplementation 52 Meta Analysis 52 serum calcium 52 microalbuminuria 52 J Am Coll 52 RNAi Therapeutics 52 postmenopausal women 52 Cohort Study 52 hypercholesterolemia 52 Age Related Macular 51 active comparator 51 Atherosclerosis Risk 51 dietary supplementation 51 concomitant medications 51 Phase 2a trial 51 geographic atrophy 51 neovascular AMD 51 #:#-# [035] 51 ALLHAT 51 epidemiologic studies